Cardiorespiratory/Metabolic Laboratory
Memphis, Tennessee, 38152, United States
NCT Number: NCT01378767
The investigators hypothesized that individuals supplementing with krill oil capsules (two grams per day) would experience enhanced improvements in health-related variables during a 21-day Daniel Fast.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Memphis, Tennessee, 38152, United States
One of the main purposes of the this investigation was to determine if krill oil supplementation (two grams per day for 21 days) enhances the effects of a 21-day Daniel Fast, particularly in regards to blood lipids and lipid peroxidation. The investigators were also interested in determining if adiponectin and/or resistin change in response to the fast, as these adipokines could potentially mediate the favorable glucoregulatory changes the investigators observed in our initial investigation of a 21-day Daniel Fast. Finally, the investigators sought to determine the changes in macronutrient and micronutrient intake during a Daniel Fast, and how these dietary changes affect our selected hemodynamic, anthropometric, blood lipid, glucoregulatory, oxidative stress, inflammatory, renal, and hepatic biomarkers.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
During a 21-day Daniel Fast, group one supplemented with krill oil capsules (two grams per day) while group two supplemented with a placebo (coconut oil capsules at two grams per day).
Other names: Now Foods Neptune Krill Oil, 1000 mg- 60 Soft Gels, Brand NOW, Part Numbers 14431, 1627, 82048, NOW-01627, NWF-16270, NWF622, UPC 733739016270, Now Foods Coconut Oil, 1000 mg- 120 Soft Gels, Part Numbers 091363-2, 1718, 18918, 24230, 5933510, 6485, 71668, 806542, NWF-17185, NWF119, UPC 733739017185
Time frame: Change from baseline at 3 weeks
Total Cholesterol, LDL-C, HDL-C, VLDL-C, Triglyerides
Time frame: Change from baseline at 3 weeks
Blood glucose, blood insulin, Serum resistin, serum adiponectin
Time frame: Change from baseline at 3 weeks
Plasma malondialdehyde, plasma hydrogen peroxide, plasma nitrate/nitrite, Trolox Equivalent Antioxidant Capacity (measured in serum)
Time frame: Change from baseline at 3 weeks
Systolic blood pressure, diastolic blood pressure
Time frame: Change from baseline at 3 weeks
Time frame: Change from baseline at 3 weeks
bodyweight, body mass index, waist circumference, hip circumference, body fat percentage, fat mass, fat free mass
Time frame: Change from baseline at 3 weeks
Blood urea nitrogen, creatinine, sodium, potassium, carbon dioxide, calcium, protein, albumin, globulin, bilirubin, alkaline phosphatase, aspartate transaminase, alanine transaminase
Time frame: Change from baseline at 3 weeks
White blood cells, red blood cells, hemoglobin, hematocrit, mean cell volume, mean cell hemoglobin, mean corpuscular hemoglobin concentration, red blood cell distribution width, platelets, neutrophils, lymphocytes, monocytes, eosinophils, basophils
University of Memphis
Other
Biochemical, Hemodynamic, and Anthropometric Effects of a 21-day Daniel Fast in Men and Women
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04057339
Behavior, Fasting
La Jolla, California, United States
View Trial DetailsNCT00523627
Behavior, Body Weight
Phoenix, Arizona, United States
View Trial DetailsNCT07216989
Behavior, Fasting
Minneapolis, Minnesota, United States
View Trial DetailsNCT07695480
Behavior, Body Weight
Elâzığ, Turkey (Türkiye)
View Trial Details